Stopping Cardiovascular Treatments and Mortality in a MICU

NCT04121429 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2019-10-09

No results posted yet for this study

Summary

Cardiovascular treatments should not be interrupted following hospital admission, in order to decrease patients' morbidity. However, following ICU admission, such treatments are frequently interrupted and/or modified. The question of the study is to investigate wether such treatment interruption might be responsible for prognosis modifications.

Conditions

Interventions

OTHER

Observation

No intervention will be performed

Sponsors & Collaborators

  • University Hospital, Brest

    lead OTHER

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-02
Primary Completion
2019-11-02
Completion
2019-11-02

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04121429 on ClinicalTrials.gov